Cheap, Copycat Ozempic Was Supposed to Go Away It’s Still Everywhere.
LegitScript also monitors certain health-related advertisements on social platforms. So far in 2024, the company has witnessed a spike in the number of “violative or problematic” GLP-1 ads, including those making false claims about what the drugs can do and ads from unlicensed pharmacies. In the first half of 2024, LegitScript has seen twice as […]
Cheap, Copycat Ozempic Was Supposed to Go Away It’s Still Everywhere. Read More »